A First-Line CDK4/6 Inhibitor Combination Therapy: Clinical Trial Evidence Complemented by a Real-World Effectiveness Evaluation
Presented by Pfizer
Presented by Pfizer
Presented by Gilead Sciences, Inc.
Presented by Clinicial Care Options, LLC
This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Lilly, Merck Sharp & Dohme LLC, and Sanofi
Presented by Research To Practice
This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo, and Seagen Inc. Additional supporters to be announced.
Presented by Agendia, Inc.
Presented by Biotheranostics, A Hologic Company
Presented by Seagen Inc.
Presented by Natera
Presented by Society of Nuclear Medicine and Molecular Imaging
This activity is supported by educational grants from GE Healthcare and SNMMI Value Initiative
Presented by Research To Practice
This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Daiichi Sankyo, Lilly, Novartis, and Sanofi. Additional supporters to be announced.
Presented by Lilly Oncology
Presented by Exact Sciences
Presented by Daiichai Sankyo, Inc., and AstraZeneca
Subscribe to get regular news updates from SABCS.org and SABCS Meeting News.